These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
395 related items for PubMed ID: 22805163
1. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy. Green DA, Rink M, Hansen J, Cha EK, Robinson B, Tian Z, Chun FK, Tagawa S, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF. BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163 [Abstract] [Full Text] [Related]
2. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. Lucca I, Hofbauer SL, Leitner CV, de Martino M, Özsoy M, Susani M, Shariat SF, Klatte T. Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373 [Abstract] [Full Text] [Related]
3. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR. BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341 [Abstract] [Full Text] [Related]
4. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN. BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [Abstract] [Full Text] [Related]
5. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Mitra AP, Skinner EC, Miranda G, Daneshmand S. BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881 [Abstract] [Full Text] [Related]
6. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM. Scand J Urol Nephrol; 2011 Sep; 45(4):251-7. PubMed ID: 21388337 [Abstract] [Full Text] [Related]
7. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder. Potretzke A, Hillman L, Wong K, Shi F, Brower R, Mai S, Cetnar JP, Abel EJ, Downs TM. Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498 [Abstract] [Full Text] [Related]
8. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [Abstract] [Full Text] [Related]